The Pharmacogenetic Rescue of Side-Lined Anticancer Drugs to the Front-Line: Gefitinib as a Case Example.
Li-Wan-Po, Alain
The Pharmacogenetic Rescue of Side-Lined Anticancer Drugs to the Front-Line: Gefitinib as a Case Example. [electronic resource] - The Annals of pharmacotherapy Feb 2011 - 263-75 p. digital
Publication Type: Journal Article; Review
1542-6270
10.1345/aph.1P496 doi
Antineoplastic Agents--pharmacokinetics
Carcinoma, Non-Small-Cell Lung--drug therapy
Clinical Trials, Phase III as Topic
Drug Resistance, Neoplasm
ErbB Receptors--antagonists & inhibitors
Gefitinib
Humans
Lung Neoplasms--drug therapy
Mutation
Prospective Studies
Quinazolines--pharmacokinetics
Retrospective Studies
Risk Assessment
Technology Transfer
The Pharmacogenetic Rescue of Side-Lined Anticancer Drugs to the Front-Line: Gefitinib as a Case Example. [electronic resource] - The Annals of pharmacotherapy Feb 2011 - 263-75 p. digital
Publication Type: Journal Article; Review
1542-6270
10.1345/aph.1P496 doi
Antineoplastic Agents--pharmacokinetics
Carcinoma, Non-Small-Cell Lung--drug therapy
Clinical Trials, Phase III as Topic
Drug Resistance, Neoplasm
ErbB Receptors--antagonists & inhibitors
Gefitinib
Humans
Lung Neoplasms--drug therapy
Mutation
Prospective Studies
Quinazolines--pharmacokinetics
Retrospective Studies
Risk Assessment
Technology Transfer